{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:38:54Z","timestamp":1765280334648,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.diabres.2022.110019","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T11:41:36Z","timestamp":1659440496000},"page":"110019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effectiveness and safety of new oral and injectable agents for in-hospital management of type 2 diabetes in general wards: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"191","author":[{"given":"Mar\u00eda Juliana","family":"Soto-Ch\u00e1vez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar Mauricio","family":"Mu\u00f1oz-Velandia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Alzate-Granados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Ernesto","family":"Lombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Cristina","family":"Henao-Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"G\u00f3mez-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.110019_b0005","unstructured":"Dhatariya K, Corsino L UG. Management of diabetes and hyperglycemia in hospitalized patients [internet]. 2020. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279093\/."},{"key":"10.1016\/j.diabres.2022.110019_b0010","doi-asserted-by":"crossref","unstructured":"Association AD. Standards of Medical Care in Diabetes\u2014202Diabetes Care [Internet]. 2022 Jan 1;45(Supplement_1):S1\u2013Available from: https:\/\/diabetesjournals.org\/care\/article\/45\/Supplement_1\/S1\/138921\/Introduction-Standards-of-Medical-Care-in-Diabetes.","DOI":"10.2337\/dc22-Sint"},{"key":"10.1016\/j.diabres.2022.110019_b0015","doi-asserted-by":"crossref","unstructured":"Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol [Internet]. 2021;9(3):174\u201388. Available from: http:\/\/dx.doi.org\/10.1016\/S2213-8587(20)30381-8.","DOI":"10.1016\/S2213-8587(20)30381-8"},{"key":"10.1016\/j.diabres.2022.110019_b0020","doi-asserted-by":"crossref","unstructured":"Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 Trial). Diabetes Care [Internet]. 2007 Sep 1;30(9):2181\u20136. Available from: https:\/\/diabetesjournals.org\/care\/article\/30\/9\/2181\/29385\/Randomized-Study-of-Basal-Bolus-Insulin-Therapy-in.","DOI":"10.2337\/dc07-0295"},{"key":"10.1016\/j.diabres.2022.110019_b0025","doi-asserted-by":"crossref","unstructured":"Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care [Internet]. 2011 Feb 1;34(2):256\u201361. Available from: https:\/\/diabetesjournals.org\/care\/article\/34\/2\/256\/39131\/Randomized-Study-of-Basal-Bolus-Insulin-Therapy-in.","DOI":"10.2337\/dc10-1407"},{"key":"10.1016\/j.diabres.2022.110019_b0030","doi-asserted-by":"crossref","unstructured":"Pasquel FJ, Hinedi Z, Umpierrez GE, Klein R, Adigweme A, Coralli R, et al. Metformin-associated lactic acidosis. Am J Med Sci [Internet]. 2015 Mar;349(3):263\u20137. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915300999.","DOI":"10.1097\/MAJ.0b013e3182a562b7"},{"key":"10.1016\/j.diabres.2022.110019_b0035","doi-asserted-by":"crossref","unstructured":"Huang W, Castelino RL, Peterson GM. Lactic acidosis and the relationship with metformin usage. Medicine (Baltimore) [Internet]. 2016 Nov;95(46):e4998. Available from: https:\/\/journals.lww.com\/00005792-201611150-00005.","DOI":"10.1097\/MD.0000000000004998"},{"key":"10.1016\/j.diabres.2022.110019_b0040","doi-asserted-by":"crossref","unstructured":"Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacother J Hum Pharmacol Drug Ther [Internet]. 2012 Jul;32(7):613\u20137. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.2011.01088.x.","DOI":"10.1002\/j.1875-9114.2011.01088.x"},{"issue":"9","key":"10.1016\/j.diabres.2022.110019_b0045","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-019-1184-8","article-title":"Debate on insulin vs non-insulin use in the hospital setting\u2014is it time to revise the guidelines for the management of inpatient diabetes?","volume":"19","author":"Pasquel","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.diabres.2022.110019_b0050","doi-asserted-by":"crossref","unstructured":"Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, et al. Thiazolidinedione use, fluid retention, and congestive heart failure. Diabetes Care [Internet]. 2004 Jan 1;27(1):256\u201363. Available from: https:\/\/diabetesjournals.org\/care\/article\/27\/1\/256\/26599\/Thiazolidinedione-Use-Fluid-Retention-and.","DOI":"10.2337\/diacare.27.1.256"},{"key":"10.1016\/j.diabres.2022.110019_b0055","doi-asserted-by":"crossref","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ [Internet]. 2021 Mar 29;n160. Available from: https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.n160.","DOI":"10.1136\/bmj.n160"},{"key":"10.1016\/j.diabres.2022.110019_b0060","first-page":"1","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2022.110019_b0065","first-page":"4","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2022.110019_b0070","unstructured":"Holger Sch\u00fcnemann, Jan Bro\u017cek, Gordon Guyatt AO. GRADE Handbook [Internet]. 2013. Available from: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html#h.fd20fe6dy7ea."},{"key":"10.1016\/j.diabres.2022.110019_b0075","doi-asserted-by":"crossref","unstructured":"Valentine JC, Thompson SG. Issues relating to confounding and meta-analysis when including non-randomized studies in systematic reviews on the effects of interventions. Res Synth Methods [Internet]. 2013 Mar;4(1):26\u201335. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jrsm.1064.","DOI":"10.1002\/jrsm.1064"},{"key":"10.1016\/j.diabres.2022.110019_b0080","doi-asserted-by":"crossref","unstructured":"Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol [Internet]. 2017;5(2):125\u201333. Available from: http:\/\/dx.doi.org\/10.1016\/S2213-8587(16)30402-8.","DOI":"10.1016\/S2213-8587(16)30402-8"},{"key":"10.1016\/j.diabres.2022.110019_b0085","doi-asserted-by":"crossref","unstructured":"Vellanki P, Rasouli N, Baldwin D, Alexanian S, Anzola I, Urrutia M, et al. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial. Diabetes, Obes Metab [Internet]. 2019;21(4):837\u201343. Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L625544649&from=export.","DOI":"10.1111\/dom.13587"},{"issue":"1","key":"10.1016\/j.diabres.2022.110019_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjdrc-2017-000394","article-title":"Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients","volume":"5","author":"Garg","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"11","key":"10.1016\/j.diabres.2022.110019_b0095","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.2337\/dc13-0277","article-title":"Safety and efficacy of sitagliptin therapy for the inpatient management of generalmedicine and surgery patients with type 2 diabetes: A pilot, randomized, controlled study","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.110019_b0100","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/dc18-1760","article-title":"A randomized controlled trial on the safety and efficacy of exenatide therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes","volume":"42","author":"Fayfman","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110019_b0105","doi-asserted-by":"crossref","unstructured":"Fushimi N, Shibuya T, Yoshida Y, Ito S, Hachiya H, Mori A. Dulaglutide\u2010combined basal plus correction insulin therapy contributes to ideal glycemic control in non\u2010critical hospitalized patients. J Diabetes Investig [Internet]. 2020 Jan 28;11(1):125\u201331. Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2004014282&from=export.","DOI":"10.1111\/jdi.13093"},{"issue":"5\u20136","key":"10.1016\/j.diabres.2022.110019_b0110","first-page":"349","article-title":"GLP1 receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in type 2 diabetes within enhanced recovery after surgery (ERAS) protocols","volume":"59","author":"Kaneko","year":"2019","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.diabres.2022.110019_b0115","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Belmonte LM, Osuna-S\u00e1nchez J, Rico-Robles JI, Ricci M, Lara JP, G\u00f3mez-Huelgas R. Simplified glycaemic management for patients with type 2 diabetes admitted for acute decompensated heart failure using linagliptin. Med Clin (Barc) [Internet]. 2022;158(4):173\u20137. Available from: https:\/\/doi.org\/10.1016\/j.medcli.2021.02.009.","DOI":"10.1016\/j.medcli.2021.02.009"},{"issue":"16","key":"10.1016\/j.diabres.2022.110019_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10163540","article-title":"Efficacy and safety of empagliflozin continuation in patients with type 2 diabetes hospitalised for acute decompensated heart failure","volume":"10","author":"P\u00e9rez-Belmonte","year":"2021","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.diabres.2022.110019_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7090271","article-title":"Use of linagliptin for the management of medicine department inpatients with type 2 diabetes in real-world clinical practice (lina-real-world study)","volume":"7","author":"P\u00e9rez-Belmonte","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2022.110019_b0130","doi-asserted-by":"crossref","unstructured":"del Olmo-Garc\u00eda MI, Herv\u00e1s Mar\u00edn D, Caudet Esteban J, Ballesteros Martin-Portugu\u00e9s A, Cerver\u00f3 Rubio A, Arnau Vives MA, et al. Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study. J Int Med Res [Internet]. 2020 Jun 21;48(6):030006052092606. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/0300060520926063.","DOI":"10.1177\/0300060520926063"},{"key":"10.1016\/j.diabres.2022.110019_b0135","doi-asserted-by":"crossref","unstructured":"Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes \u2013 global burden of disease and forecasted trends. J Epidemiol Glob Health [Internet]. 2019;10(1):107. Available from: https:\/\/www.atlantis-press.com\/article\/125921499.","DOI":"10.2991\/jegh.k.191028.001"},{"key":"10.1016\/j.diabres.2022.110019_b0140","doi-asserted-by":"crossref","unstructured":"Pratiwi C, Mokoagow MI, Made Kshanti IA, Soewondo P. The risk factors of inpatient hypoglycemia: A systematic review. Heliyon [Internet]. 2020 May;6(5):e03913. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020307581.","DOI":"10.1016\/j.heliyon.2020.e03913"},{"key":"10.1016\/j.diabres.2022.110019_b0145","doi-asserted-by":"crossref","unstructured":"Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S, et al. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia [Internet]. 2009 Oct 14;52(10):2046\u201355. Available from: http:\/\/link.springer.com\/10.1007\/s00125-009-1472-y.","DOI":"10.1007\/s00125-009-1472-y"},{"key":"10.1016\/j.diabres.2022.110019_b0150","doi-asserted-by":"crossref","unstructured":"Russell-Jones D. The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes. Int J Clin Pract [Internet]. 2010 Sep;64(10):1402\u201314. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2010.02465.x.","DOI":"10.1111\/j.1742-1241.2010.02465.x"},{"key":"10.1016\/j.diabres.2022.110019_b0155","doi-asserted-by":"crossref","unstructured":"Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB, et al. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol [Internet]. 2018 Aug;6(8):605\u201317. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301049.","DOI":"10.1016\/S2213-8587(18)30104-9"},{"key":"10.1016\/j.diabres.2022.110019_b0160","doi-asserted-by":"crossref","unstructured":"Sun F, Yu K, Yang Z, Wu S, Zhang Y, Shi L, et al. Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysis. Exp Diabetes Res [Internet]. 2012;2012:1\u201314. Available from: http:\/\/www.hindawi.com\/journals\/jdr\/2012\/230624\/.","DOI":"10.1155\/2012\/230624"},{"key":"10.1016\/j.diabres.2022.110019_b0165","doi-asserted-by":"crossref","unstructured":"Li D, Wang T, Shen S, Fang Z, Dong Y, Tang H. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes, Obes Metab [Internet]. 2017 Mar;19(3):348\u201355. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dom.12825.","DOI":"10.1111\/dom.12825"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:22:21Z","timestamp":1759173741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":33,"alternative-id":["S0168822722008336"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110019","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of new oral and injectable agents for in-hospital management of type 2 diabetes in general wards: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110019"}}